At the news
? BEARISHIMPACT 6/10 CLUSTER filed Mar 1, 2026 at 19:00 ET
Multiple insiders at Arcutis Biotherapeutics sold shares in a coordinated open-market cluster totaling $1.65M over two days, including CFO Latha Vairavan. These sales coincide with routine stock award grants, suggesting pre-arranged 10b5-1 plans. The total value represents 0.06% of market cap, modest but notable due to C-suite participation.
- Seven open-market sales totaling $1.65M occurred on March 2, 2026, by five insiders including CFO Latha Vairavan.
- Concurrent with sales, five insiders received non-cash stock grants totaling 226,000 shares ($0 value).
- Sales represent ~0.06% of $2.9B market cap, not large in absolute terms but concentrated among executives.
- All transactions occurred within a 7-day window, indicating coordinated timing, likely under 10b5-1 plans.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access